Pick a time period -
No more available filters You need to apply a filter before selecting newsroom

Use our filters to get your customized news. Save and subscribe to as many filters as you want, get the news that YOU are interested in right in your mailbox, RSS feed or in your personalized dashboard. Share your stories, news, multimedia and pressreleases and get a wider audience with news.cision.com.

CS MEDICA A/S: CS MEDICA’s products available on Amazon Sweden

CS MEDICA A/S ("CS MEDICA" or the "Company") today announces that the Company is expanding its sales channels by launching products through Amazon Sweden. The products CANNASEN®CBD Pain Patch, Protective Nasal Gel and CBD PSOR+ATOPIC Lotion, Anti-Hair Loss Serum, and Hand Cream are now available on Amazon Sweden’s webshop.CS MEDICA continues to expand the availability of CANNANSEN products through sales channels and can announce that CANNASEN® CBD Pain Patch, Protective Nasal Gel, and CBD PSOR+ATOPIC Lotion, Anti-Hair Loss Serum, and Hand Cream are now available on Amazon Sweden webshop.

Redsense announces new CEO

Redsense Medical announces that the highly experienced global life science leader Pontus Nobréus is appointed new CEO. Nobréus combines a track record of driving sales through well-targeted commercialization with an unwavering commitment to innovation that truly benefits patients, and takes over the helm at Redsense to speed up its ongoing journey of growth. The qualified and internationally proven chief executive brings wide experience in diagnostics, medtech, and international business development and sales to the role. He will succeed outgoing CEO Patrik Byhmer, co-founder and largest

Annual General Meeting Copenhagen, Denmark, 2 May 2022 – FluoGuide A/S (“FluoGuide” or the “Company”) hereby convenes an annual general meeting to be held on 18 May 2022.

To the shareholders of FluoGuide A/SThe board of directors hereby convenes an annual general meeting of FluoGuide to be held on: Wednesday 18 May 2022 at 11:00 (CET) at the Company’s premises, Ole Maaløes Vej 3, room M6, DK-2200 Copenhagen N, Denmark. The agenda for the general meeting is as follows: 1. ELECTION OF CHAIRMAN OF THE MEETING 2. REPORT ON THE ACTIVITIES OF THE COMPANY IN THE PAST FINANCIAL YEAR 3. PRESENTATION OF THE ANNUAL REPORT WITH AUDITORS' REPORT FOR ADOPTION 4. RESOLUTION ON COVERING OF LOSSES IN ACCORDANCE WITH THE ADOPTED ANNUAL REPORT 5. ELECTION OF

FREYR Battery CEO joins HRH Crown Prince Haakon during official visit to Sweden

New York, Oslo and Luxembourg, May 2, 2022, FREYR Battery (NYSE: FREY) (“FREYR”), a developer of clean, next-generation battery cell production capacity, is pleased to announce that CEO Tom Einar Jensen will participate in the delegation of His Royal Highness (“HRH”) the Crown Prince of Norway during an official visit to Stockholm, Sweden, on May 2-4. The purpose of the royal delegation is to engage with Her Royal Highness the Crown Princess of Sweden and other delegates from across the Swedish battery cell industry on how Norway and Sweden can build a stronger green industry together

Caverion acquires Wind Controller, a Finnish service company in the wind power industry

Caverion Corporation Investor news 2 May 2022 at 1.00 p.m. EESTCaverion acquires Wind Controller, a Finnish service company in the wind power industry Caverion has today closed an agreement to acquire the shares of the Finnish service company Wind Controller (“WiCo”). WiCo is the leading technical consultant and service provider for the Finnish wind power industry. Its customer base includes turbine suppliers and wind farm owners, operators and developers. By entering the wind power segment, Caverion widens its offering in the energy sector. The transaction complements Caverion’s strong

InDex Pharmaceuticals strengthens the organization with Eva Arlander as Chief Development Officer and announces changes in the composition of the management team

May 2, 2022 – InDex Pharmaceuticals Holding AB (publ) today announced that the company has appointed Eva Arlander as Chief Development Officer. Eva will also be part of the management team, together with acting Chief Executive Officer and Chief Financial Officer Johan Giléus, Chief Medical Officer Anders Bröijersén and Chief Scientific Officer Charlotte Admyre.Eva Arlander is a pharmacist and PhD in clinical pharmacology, and has previously held senior positions at Astra Zeneca, Medivir and Affibody with a main focus on clinical development, as well as department head at the Medical

Aquaporin announces new Chief Financial Officer

Company announcement no. 5/2022 Changes to the Executive Management of Aquaporin Aquaporin A/S (“Aquaporin” or the “Company”) is very pleased to announce the appointment of Klaus Juhl Wulff as the Company’s new CFO and member of the executive management with effect from 20 May, 2022. Klaus Juhl Wulff brings significant experience in finance and accounting from his career, which includes positions as interim CFO in FLSmidth’s cement division (2021), CFO of Cobham Satcom (2018-2021), division CFO in Berendsen Facility Division (2016-2018), CFO of Stena Recycling (2014-2016) and most

Enersense looks into building its own solar power plant in Pori’s Mäntyluoto

Enersense International PlcPress release 2 May 2022 at 12:20 p.m.Enersense International Plc, a provider of zero-emission energy solutions, is planning on building a 20 MW solar power plant in Mäntyluoto in Pori. A study of the project is currently underway, and an investment decision will be made later. The size of the investment is 10-12 million euros. The solar power plant would come on the same plot where Enersense Offshore Oy, specialised in offshore wind power, already operates. “This is one of Finland's largest solar power projects to date. Another great thing about the

Citycon to publish its Interim Report for January-March 2022 on Thursday, 5 May 2022 approximately at 8:30 pm EEST

CITYCON OYJ   Investor News   2 May 2022 at 12:15 hrsCitycon will publish its Interim Report for 1 January – 31 March 2022 on Thursday, 5 May 2022 approximately at 8:30 pm EEST. The report will be available on Citycon’s website immediately after publication.Citycon's investor, analyst and press conference call and live audiocasting will held on Friday, 6 May 2022 at 10 am EEST. The audiocast can be participated by calling in and followed live on the following website: https://citycon.videosync.fi/2022-q1 

ICA Real Estate acquires Alecta Fastigheter’s share in Långeberga Logistik

ICA Real Estate today entered into an agreement and took possession of Alecta Fastigheter’s 50% share in the jointly owned company Långeberga Logistik AB.ICA Real Estate has carried out the acquisition by exercising a buy-back option. The acquisition gives ICA Real Estate sole right of disposal over the property and ICA Real Estate the ability to develop ICA’s largest logistics property in a more agile way. ICA Real Estate and Alecta Fastigheter continue to jointly own Ancore Fastigheter together. The Långeberga Logistik property covers more than 105,600 square metres and has a market

Spinnova Plc: Allan Andersen appointed as Chief Sales Officer and member of the management team

SPINNOVA PLC, COMPANY RELEASE, 2 MAY 2022 at 12:00 NOON  EEST  Spinnova Plc: Allan Andersen appointed as Chief Sales Officer and member of the management team   Spinnova has appointed Allan Andersen as Chief Sales Officer and a member of the management team. This position is new in Spinnova and is an essential role supporting Spinnova’s growth and scaling.  He starts in his position today, 2 May 2022 and reports to the CEO.   Allan Andersen has 20 years of experience from various Commercial and Business Development roles in the sporting goods industry. Prior to joining

Ferd acquires 33 percent of the diagnostics company Aidian

The Finnish company Aidian develops, manufactures and sells instruments and tests that are used in such fields as primary care to provide quick and accurate test results. Aidian’s range of tests addresses several global health problems, such as antimicrobial resistance (AMR), diabetes and colorectal cancer. Aidian has tests that are intended to reduce unnecessary prescriptions of antibiotics, which is a driver behind the growing threat from AMR and antibiotic-resistant bacteria.  “Finnish company Aidian has built up a leading, global position in point-of-care diagnostics. The company’s

Invitation to audiocast for Devyser’s Q1 Report 2022

On Wednesday May 11, at 09.00 CET, Devyser Diagnostics AB will host an online presentation of its Q1 2022 interim report (which will have been published earlier on May 11, at 08.00 CET). The presentation will be held in English.    This call will be an audiocast only and questions can be emailed to fredrik.alpsten@devyser.com in advance or during the call and will be answered at the end of the presentation.   The presentation will be webcast and can be accessed from the following web address:  https://tv.streamfabriken.com/devyser-diagnostics-q1-2022    Speakers: CEO

Ework Group AB (publ) publishes Interim Report, January – March 2022: New record quarter and strengthened position

“Ework has had a positive start to 2022 with yet another record quarter. The market is strong and we had for the first time over 12,000 consultants on assignment. Net sales increased by 24 percent and what is especially pleasing is that EBIT amounted to SEK 47 M, an increase by 71 percent. The increased profitability shows increased cost efficiency, scalability and a higher added value of our services." Extract from CEO Karin Schreil’s commentary to the Interim ReportFirst quarter 2022 compared to 2021 · Net sales increased by 24 percent to SEK 3,924 M (3,165). The increase is due

Pharmacolog publishes annual report for 2021

Pharmacolog publishes annual report for 2021 Pharmacolog i Uppsala AB (publ) hereby announces that the Annual Report for 2021 is available on the Company’s website www.pharmacolog.com . The report has been published in Swedish and English. The annual report for the financial period 1 January – 31 December 2021 is now available at: Financial reports at Pharmacologs website . For more information, please visit www.pharmacolog.com or contact:

NOTIFICATION OF MANAGERS’ AND CLOSELY RELATED PARTIES’ TRANSACTIONS WITH DAMPSKIBSSELSKABET NORDEN A/S’ SHARES IN CONNECTION WITH SHARE BUY-BACK PROGRAM

ANNOUNCEMENT NO. 110 - 2 MAY 2022 In connection with the announced share buy-back program in Dampskibsselskabet NORDEN A/S, A/S Motortramp participates by selling shares pro rata in order to maintain the current ownership of just under 32% of the shares in Dampskibsselskabet NORDEN A/S. The market will be informed accordingly – see the attached file and announcement no. 56/2022. Kind regards, Dampskibsselskabet NORDEN A/S Martin Badsted CFO For further information:Thomas France, Investor Communications Partner, tel.: 3315 0451

#22-150 Stressed market conditions on all equities and securitized derivatives

A state of stressed market conditions has been decided for all equities and securitized derivatives. Stressed market conditions will remain until close of business as of May 2, 2022.When stressed market is called for, market makers are allowed to quote prices with a larger spread than normal. Please check our website www.ngm.se for information regarding the affected instruments. For further information concerning this NGM notice please contact: NGM market surveillance, +46 8 566 390 55, marketsurveillance@ngm.se Nordic Growth Market NGM AB

DanCann Pharma A/S strengthens the Board of Directors with experienced investment profile Tue Østergaard

COPENHAGEN, Denmark, 2 May 2022 - DanCann Pharma A/S (SS: DANCAN) ("DanCann Pharma" or the “Company”), a Danish company powered by cannabinoids, hereby announce that Tue Østergaard, CEO of HC Andersen Capital, was elected to the Company's Board of Directors.At DanCann Pharma's Annual General Meeting on Wednesday 27 April 2022, Tue Østergaard, CEO of HC Andersen Capital, was elected to the Company's Board of Directors. In connection with the election to the Board of Directors, Carsten Trads was able to welcome Tue Østergaard. The experienced investment profile, who is CEO of the fast-

DAMPSKIBSSELSKABET NORDEN A/S – WEEKLY REPORT ON SHARE BUY-BACK

ANNOUNCEMENT NO. 109 - 2 MAY 2022 On 3 March 2022, NORDEN initiated a share buy-back programme in accordance with Regulation No. 596/2014 of the European Parliament and Council of 16 April 2014 (MAR) and Commission Delegated Regulation (EU) 2016/1052, (Safe Harbour regulation). The share buy-back programme runs from 3 March 2022 up to and including no later than end April 2022. For details, please see announcement no. 56 of 3 March 2022. Under the share buy-back programme, NORDEN will purchase shares for up to a total of USD 30 million (approximately DKK 201.5 million). Under the

Herantis Pharma to Participate in Investor and Partnering Conferences

Herantis Pharma Plc, Press Release, 2 May 2022 at 11:15 EEST   Herantis Pharma Plc (“Herantis”), developing disease modifying therapies for Parkinson’s disease, today announced that members of the Herantis management team will be attending and holding 1x1 meetings with investors and pharmaceutical companies at the following conferences:   Nordic Health Summit Japan (Virtual) Herantis will participate in the Nordic Pitch Showcase session. 1x1 meetings will be scheduled during May 11-13, 2022      Inderes Investment Day May 23, 2022 The presentation will be

I love working under pressure, it’s what makes my job fun! – Ilan Guiladi

Ilan Guiladi has worked in purchasing and supplier sourcing throughout most of his career. As Head of Sourcing at KraftPowercon, he manages the day-to-day operations of our global purchasing division. We had a chat with Ilan to learn more about what a regular day looks like in our purchasing department. Hi Ilan! Tell us about your professional background.Before joining KraftPowercon in 2012, I ran my own consulting business where I supported numerous companies with everything from project management and purchasing to contract negotiation and sourcing of suppliers. KraftPowercon

Visma achieves 28% growth in Annualised Repeatable Revenue (ARR) in Q1, reaching € 1 744m

Acquisition activity was also high with 15 companies joining the Visma family. Read the full Q1 report  Summary – Q1, 2022 Notable results for Visma · Annualised Repeatable Revenue (ARR) grew 28 % year over year to reach € 1 744 million · Visma’s revenue grew 18 % compared to Q1 last year, to € 579 million · SaaS remains a key driver of revenue growth, with combined revenue from SaaS subscriptions and transactions growing 27 % compared to the same period last year. · Visma

Valmet to supply automation technology to Lemit Papers in Morbi, India

Valmet Oyj’s trade press release on May 2, 2022 at 11:00 a.m. EESTValmet will supply a mill wide Valmet DNA Automation System  with the new Valmet DNA User Interface  and consistency measurements package to Lemit Papers in Morbi, India. The target of the investment is to ensure a smooth start-up, to optimize the equipment efficiency and to achieve premium board quality. The order was included in Valmet's orders received of the first quarter 2022.

There are no items matching the current filter
There are no more items matching the current filter
Back to top